Ascentage Pharma is a global, clinical-stage biotechnology company engaged in developing novel therapies for cancers, CHB, and senesce diseases.
View all
WuXi Biologics
China
Clover Biopharmaceuticals
Post IPO Equity • Chengdu, China
Zai Lab
Post IPO Equity • Shanghai, China
Imvax
Series C • Philadelphia, United States
Connect Biopharma
Series C • Jiangsu, China
Genentech
Venture • South San Francisco, United States
Tianjin CanSino Biologics
Series E • Tianjin, China
Cathay Biotech
Series B • Shanghai Shi, China
I-Mab Biopharma
Post IPO Equity • Shanghai, China
Adlai Nortye Biopharma
Series D • Hangzhou, China
Celsius Therapeutics
Series B • Cambridge, United States
ARCA biopharma
Westminster, United States